EC approves Merck’s bladder cancer combination therapy in adults
Merck & Co., got approval from the European Commission to market its combination therapy to treat metastatic urothelial cancer or bladder cancer in
Drugs
Health
Pharma
Drugs
Health
Pharma
Simple blood tests can map women’s heart disease risks when done early
A simple blood test — done when women are in their 30s — can measure types of proteins in the blood that may
Drugs
Health
Pharma
Novavax’s vaccine targeting JN.1 strain of Covid-19 virus gets FDA approval
The US Food and Drug Administration cleared Novavax’s Covid-19 vaccine, targeting the JN.1 strain, for people 12 years of age and older, according
Drugs
Health
Pharma
Emergent gets US drug regulator’s nod to use its smallpox vaccine for mpox
Emergent BioSolutions Inc., got the US drug regulator’s approval to expand its smallpox vaccine use to treat mpox, according to a company statement.
Drugs
Health
Pharma
UNICEF issues emergency tender to purchase mpox vaccines
United Nations Children’s Fund, the world's largest single vaccine buyer, has issued an emergency tender to buy mpox vaccines to fight the rapid
Drugs
Health
Medical
Mitochondrial DNA insertion into brain cells’ nucleus linked to early death
Bharti Jayshankar August 30, 2024: A recent study has found that the insertion of mitochondrial DNA into the nucleus of brain cells, a
Drugs
Health
Medical
Live kidney donation is safer than previously thought
Bharti Jayshankar August 30, 2024: Kidney donors face a lower risk of death than previously believed, according to a new research. Data from
Drugs
Health
Pharma
Cigarette smoking may help fight Parkinson’s disease: Harvard research
Smoking cigarettes may protect humans from neurodegeneration and prevent the accumulation of a key Parkinson’s-associated protein in the brain, new research on mice
Drugs
Health
Pharma
US smokers need photo ID to prove new age limit set by the FDA
The US drug regulator raised the age limit of people who want to buy tobacco products by three years to 30, and retailers
Drugs
Health
Pharma
Neurocine’s mid-stage trial drug cuts schizophrenia severity symptoms
US-based Neurocrine Biosciences’ trial drug for treating schizophrenia reduced the severity of the disease symptoms in a mid-stage study of 210 adult participants.